TESTFYRA LIMITED

Financial Health Score: B-

The patient is stable and breathing on its own, but it has been losing weight for several years. While there are no immediate signs of cardiac arrest (insolvency), the chronic erosion of the company's financial muscle mass (net assets) over the last five years is a concerning symptom that requires attention. The recent increase in staff without a corresponding increase in asset base suggests the business may be stretching its current metabolic resources.

Key Vital Signs

1. Liquidity (Current Ratio): 1.61 Current Assets (£73,187) / Current Liabilities (£45,501) Think of this as the company's respiratory rate. A ratio of 1.61 means the business has £1.61 in short-term assets for every £1 of short-term debt. This is a healthy breathing pattern—the company can comfortably cover its immediate obligations without gasping for cash.

2. Solvency (Net Assets): £101,510 This is the company's baseline vitality. While positive (meaning assets exceed total liabilities), it has fallen from a peak of £195,791 in 2020. The patient is solvent, but their overall constitution has weakened by nearly 50% over five years.

3. Debt Structure (Long-term Liabilities): £45,642 Long-term debts have decreased from £52,136 in the prior year. The company is successfully paying down long-term obligations, which is akin to lowering a patient's chronic blood pressure—it reduces long-term risk.

4. Staffing (Employee Count): 5 The average employee count increased from 3 to 5. This represents a significant jump in the company's "metabolic rate" (ongoing cash burn for salaries). For a micro-entity, increasing headcount by 66% is a major commitment that will require a higher caloric intake (revenue) to sustain.

Diagnosis

Condition: Chronic Asset Atrophy with Stable Short-Term Vitals

Looking at the financial X-rays, Testfyra Limited is suffering from a persistent shrinking of its balance sheet. From 2019 to 2025, total assets contracted from £310,620 down to £192,653. Similarly, net assets fell from £190,669 to £101,510.

This atrophy can be caused by one of two underlying conditions: 1. Operating Losses (Internal Bleeding): The business is trading at a loss, and these losses are eating away at the retained earnings and, consequently, the net assets. 2. Aggressive Dividend Extraction (Voluntary Weight Loss): The directors/owners are drawing out profits as dividends rather than reinvesting them, effectively slimming down the company's reserves.

The latest accounts show a drop in net assets from £126,330 down to £101,510 in just one year. Given that the company also saw a reduction in both fixed assets (from £144,993 to £119,466) and current assets (from £85,606 to £73,187), it appears the business is either consuming its own reserves to fund operations or distributing cash to the owners rather than reinvesting in the business.

The most curious symptom is the increase in staff from 3 to 5. Usually, hiring indicates growth, but the shrinking asset base suggests the opposite. This mismatch creates a risk of "cash flow anemia" if the new hires do not generate sufficient additional revenue to cover their costs.

Recommendations

1. Investigate the Source of the Atrophy: The directors must determine whether the drop in net assets is due to trading losses or dividend payouts. If the business is loss-making, immediate cost-care is required. If it is profitable but distributing all earnings, a more conservative dividend policy should be adopted to rebuild the company's financial immune system (reserves).

2. Monitor the "Metabolic Rate": With headcount increasing by 66%, the monthly cash burn will have risen sharply. Ensure that the current assets (particularly cash and trade debtors) are sufficient to cover the new, higher payroll costs. A detailed cash flow forecast for the next 12 months is essential to prevent a sudden financial arrest.

3. Rehabilitate the Asset Base: The reduction in fixed assets suggests the company may not be reinvesting in the equipment or technology required for an IT services business. Consider retaining more earnings to reinvest in the tools that will drive future revenue generation.